The Silicon Valley Health Institute August presentation will include a panel of speakers including Bernd Friedlander, DC, Len Saputo, MD, and Ahvie Herskowitz, MD. They will discuss new approaches for treating and preventing cancer. Expectations include learning about the following:
- Cancer causes and defenses
- Orthomolecular diagnosis of cancer factors
- Cancer prevention and reversal
- The effect of diet impact on cancer. In particular, impact of a high sugar diet for persons with cancer will be discussed
- The use of light therapies in treating cancer pain and in managing the peripheral neuropathy often seen with chemotherapy
- The use of Insulin Potentiation Therapy which can allows chemotherapy to enter and selectively enter and damage cancer cells. This allows a reduction of chemotherapy by 90%
Dr. Richard Kunin, MD
Richard A. Kunin, MD specializes in orthomolecular medicine and has written many booksbooks and articles on nutrition and orthomolecular medicine. He was a co-founder of the Orthomolecular Medical Society with Dr. Linus Pauling in 1976. Along with Richard Huemer, MD, he heads the Society for Orthomolecular Health-Medicine (OHM), which conducts an annual conference on nutrition science.
Dr. Kunin will discuss cancer causes and defenses, the orthomolecular diagnosis of cancer factors, cancer prevention, and reversal. For more info, read the newsletter.
Ahvie Herskowitz, MD
Dr. Ahvie Herskowitz is Clinical Professor of Medicine at UC San Francisco (UCSF) and is Founder of Anatara Medicine, a multidisciplinary integrative center in San Francisco. His training includes a medical degree from The Albert Einstein College of Medicine, residencies in Pathology and Internal Medicine, and fellowship training in Cardiology at The Johns Hopkins Medical Center. During his 12 years at Johns Hopkins, he was co-appointed in Medicine and Molecular Immunology and Microbiology. His clinical responsibilities were complemented by directing a multidisciplinary NIH-sponsored research team in the study of molecular and immunological mechanisms of heart ischemia, heart transplantation, heart failure and autoimmunity. In addition to his appointment at UCSF, he has served as Director at the Ischemia Research and Education Foundation, working with over 100 leading heart surgery hospitals around the world, dedicated to reducing adverse outcomes during and after heart surgery. In 2001, he co-founded The Institute for OneWorld Health, the first non-profit pharmaceutical company in the United States, dedicated to developing new medicines for diseases of poverty in the developing world. Throughout his career, Dr. Herskowitz has been developing novel alternative approaches towards health. Following formal training in Five Element Acupuncture in 1999, he has been dedicated to building a world-class integrative medicine team approach towards prevention and treatment of vascular, immunologic and recalcitrant chronic diseases. As Founder of Anatara, he leads a team of dedicated staff and senior advisors advancing new approaches to personalized and proactive medicine based on the convergence of seven vital disciplines.
One difficulty cancer care providers are faced with is selectively penetrating cancer cells with chemotherapy, and protecting normal cells. IPT (Insulin Potentiation Therapy) can allow chemotherapy to enter and damage cancer cells more selectively and effectively by utilizing chemotherapy in conjunction with glucose and insulin. This strategy requires only 10% of conventional chemotherapy dosing, often minimizing adverse side effects on normal cells. Cancer cells utilize more sugar than healthy cells and are therefore more sensitive to insulin. Thus, the insulin used in IPT induces cancer cells to selectively take in chemotherapy, and any other agents that are utilized. Another difficulty is targeting which natural remedies are best for individual patients. Natural remedy sensitivity testing, and tracking effectiveness of treatment using circulating tumor cell markers in blood will be discussed. For more info, read the newsletter.
Len Saputo, MD
Len is a board-certified internist with 50 years of experience. He has pioneered the development of an integrative, holistic, person-centered, preventive health care model called “Health Medicine.” He is the founder of the Health Medicine Forum, a non-profit educational foundation and the Health Medicine Center in Walnut Creek. Len is a practicing physician, motivational speaker, television and radio personality, and was formerly ranked number one in the world in men’s senior tennis by the International Tennis Federation. He is the author of the Nautilus Gold Award winning book, A Return to Healing: Radical Health Care Reform and the Future of Medicine. Len’s free website, www.DoctorSaputo.com, has more than 2500 audio and video files organized to provide completely free integrative information on more than 30 common health care conditions. Len is also deeply involved in NIH funded research at UCSF on the use of infrared light therapy to speed healing and for pain management.
The practice of medicine is entering a new era where biophysics is able to explain biochemistry and physiology and is bringing exciting new therapies into clinical practice. In this presentation Len Saputo, MD, will explain how light therapies work and what they do in clinical practice with specific reference to managing the peripheral neuropathy so often seen with chemotherapy. He will share infrared images that demonstrate the amazing scope of practice that is possible to relieve pain and speed up the healing process. For more info, read the newsletter.
Bernd Friedlander, DC
Bernd Friedlander, D.C., has a Bachelors Degree in Physical Education with emphasis in applied kinesiology from San Francisco State University, and a Doctorate of Chiropractic Degree from the Los Angeles College of Chiropractic. He has been involved in developing nutritional therapies since 1982. As result of his therapeutic formulas, he pioneered the research and use of nutrition and free form amino acids for improving athletic performance as a safe alternative to steroids.
Dr. Friedlander will discuss the use of cyproheptadine, an antihistaminic drug in cancer treatment. Cypoheptadine inhibits proliferation of hepatocellular carcinoma cells by blocking cell cycle progression through the activation of P38 MAP kinase. For more info, read the newsletter.
NOTE: Meeting starts promptly at 7pm. Main speaker presentation begins at 7:20 p.m.
